Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation

Li Wen, Dong Xingtong, Jia Qiang, Fu Wenjing, Lin Na, Liu Hua, Zhang Aihua

PDF(908 KB)
Chinese Journal of Nephrology ›› 2020, Vol. 36 ›› Issue (10) : 744-749. DOI: 10.3760/cma.j.cn441217-20191101-00132
Clinical Study

Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 36(10): 744-749. DOI: 10.3760/cma.j.cn441217-20191101-00132.

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(908 KB)

Accesses

Citation

Detail

Sections
Recommended

/